The Edit review
The first month is priced below the standing rate for a limited time, and only once.
The verdict
The Edit publishes $259 a month for compounded semaglutide, with a limited-time first month at $200. Tirzepatide is $349 after a $300 first month. Fifty states are covered.
Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
- Category
- GLP-1 telehealth
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection
- Dose pricing
- Flat across doses
- States
- 50
- From
- From $259/mo
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
- Availability
- All 50 states
The Edit sells both molecules by injection across fifty states, with prepay tiers billed once upfront and a limited-time first-month price.
Who writes the prescription, and what do they see?
A prescription precedes shipping. The pages state rates and tiers. The clinician is not described and the intake is not documented.
A first-month price is a discount, not a rate. The figure a buyer meets first is not the one they will pay. The standing rate is published beside it, which is the part that matters.
What happens when the dose goes up?
Both lines are stated flat, so the rate holds as the dose rises. The prepay tiers are about term rather than dose, so neither variable is left unstated.
What the price includes
Six months of semaglutide at the standing rate is $1,554. Prepaying brings it to $575 for three months, about $192 a month, or $1,065 for six, about $178. Tirzepatide is $349 a month, or $855 and $1,575 prepaid, about $285 and $263 a month.
What it claims, and what it cites
Both lines are compounded. A pharmacy prepares them. The FDA does not review them before dispensing. No pharmacy is named.
Where it holds up, and where it does not
- Strength: The first-month price is labeled limited time
- Strength: Standing rates published beside it
- Strength: Prepay totals stated, not just rates
- Strength: Coverage across all fifty states
- Limitation: The first figure is a one-time discount
- Limitation: Tirzepatide costs $90 more a month
- Limitation: Prepaid tiers bill in one charge
- Limitation: No compounding pharmacy is named
What the evidence says about this kind of treatment
The assessment above is about The Edit. These are about the drugs it sells, and they are traced to the primary literature.
- Right for
- A reader who reads the standing rate beside the first-order figure.
- Wrong for
- A reader budgeting six months from the first-month figure.
The evidence behind what The Edit prescribes
These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation.
- Cochrane Review of Semaglutide for Obesity: 18 Trials Graded
A 2025 Cochrane review pooled eighteen randomized trials. The weight figure is high certainty and smaller than the marketing, and almost everything else is graded lower.
- Tirzepatide vs Semaglutide: Which Works Better for Weight Loss?
In a 72-week randomized trial at weight-management doses, weight fell 20.2 percent on tirzepatide and 13.7 percent on semaglutide. Routine-care studies found a smaller gap, three to four points.
How The Edit compares
| Seller | Who it suits | Go |
|---|---|---|
| Readers choosing between formats who do not want the choice priced | See TMates → | |
| Readers who want the standard rate stated beside the introductory one before they sign up | See TeleClinic → | |
| Readers taking the longest plan, since no shorter term carries a published rate | See Telos Rx → |
More GLP-1 telehealth sellers reviews: Bionomy HealthBioverseBlis MDBlivBloom MDBloomWell Rx
Sponsored alternative
SkinnyRx
Readers choosing tirzepatide, the one line with a published standing rate
Check SkinnyRx availability →Frequently asked
- Is $200 the ongoing price?
- No. It is a limited-time first month. The standing rate is $259 a month.
- What do the prepay tiers cost?
- $575 for three months and $1,065 for six, billed once upfront, which is about $192 and $178 a month.
- Does the price rise with the dose?
- No. Both lines are stated flat across doses.
- Is The Edit legit?
- The Edit is a GLP-1 telehealth sellers service. Its stated availability: All 50 states. What our record does not establish: whether it bills insurance and how its intake works. Ask for those in writing before you pay.
- Is The Edit expensive compared with other GLP-1 telehealth sellers?
- The Edit publishes a starting figure of $259/mo. Across the 402 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $49 to $525.42 with a median of $190, which puts The Edit above the median. The other 178 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.